Pre-Implantation Methylation Screening (PIMS)
A pioneering technology to greatly increase the live birth rate and reduce the birth defects in ART practice, helping families relief from mental struggling and economic burden.
Preimplantation DNA Methylation Screening Kit (PIMS Kit)
Worldwide pioneering technology with 8 years of ingenious research and development
Three platforms based on epigenetic technology + big data
About Us
Providing integrated solution for reproduction
Making infertility and birth defects history
Guangzhou Nvwa Life Technology Co., Ltd. is a world-leading innovative company with genome epigenetics research and medical transformation platform. On two major technology platforms (the technology platform of whole-genome library preparation of trace cells and the database platform of human epigenetics), Nvwa aims for longitudinal and in-depth development and promotion of products in the epigenetic field and market, which indicate the product pathway from assisted reproductive tests, to obstetrical as well as neonatal epigenetic disease tests, and then from epigenetic diagnosis to epigenetic editing treatment.
World-class R & D team
Innovative technology in its first
BSL-2 Medical Laboratory
News Center
-
生殖醫學領域規模最大、最具影響力的國際會議——美國生殖醫學會（ASRM）2024年年會在美國科羅拉多州丹佛市圓滿落幕。來自90多個國家和地區的5000余名專家學者齊??聚一堂，共同探討生殖醫學學術挑戰、分享臨床經驗、探索前沿技術新方向。 女媧生命參加此次會議，展示了其首創的表觀遺傳檢測技術——植入前甲基化篩查（PIMS），并受邀做主題演講。此外，該公司還榮獲 ASRM 頒發的 2024 年生殖生物學與技術學會 (SRBT) 獎。 會議期間，PIMS產品和技術獲得了全球生殖行業領導者、潛在合作伙伴和客戶的高度關注和認可。女媧團隊通過互動與行業專家和與會者建立聯系，獲得對市場需求的寶貴見解并了解新技術趨勢。這些信息將幫助女媧更好地了解行業趨勢并完善其產品，使其更貼近市場需求。 女媧生命高級研發總監姚雪龍博士受邀發表題為“ 輔助生殖技術中評估胚胎質量的一種新方法： DNA甲基化”的主題演講。 他被美國生殖醫學會（ASRM）授予2024年生殖生物學與技術學... -
On August 23rd, the winners of the HICOOL 2024 Global Entrepreneurship Competition were announced at the HICOOL 2024 Global Entrepreneurs Summit. The "Pioneering Application of Epigenetics in Reproductive Medicine" project by Nuwa Life won the third prize! In this grand gathering of global wisdom, we competed with 7,406 projects and 9,700 top innovators from 124 countries and regions, showcasing our strength and innovative spirit. Receiving recognition on such an international stage is a high affirmation of our potential for future development, and we are deeply honored. We thank every partner who supports us and every team member for their hard work and relentless pursuit. It is your creativity and efforts that have made this moment possible. This honor belongs to each of us and is the result of our joint struggle. We will continue to uphold the spirit ...
-
In December 2021, Guangzhou Nvwa Life Technology Co., Ltd. signed strategic cooperation agreements with CITIC Xiangya Genetics and Reproductive Specialist Hospital, the University of Hong Kong Shenzhen Hospital, and Shenyang Shengjing Hospital, aiming to cooperate in national scientific programs, research and development, and clinical trials.
